Skip to main content

Stoke Therapeutics, Inc.

STOK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001623526

In the last 90 days, Stoke Therapeutics, Inc. insiders filed 0 open-market purchases and 6 sales; 197 institutions reported holding it in 13F filings for Q2 2026, worth $2.49B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Stoke Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
6 filings
3 insiders, $1.26M in total
Insiders trading
3
Net value
−$1.26M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Stoke Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Stoke Therapeutics, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Cumbo AlexanderDirector–Sep 25, 20261
Ticho BarryCHIEF MEDICAL OFFICER20,110Sep 3, 202614
Kaye Edward M. MDDirector124,557Aug 18, 20268
Allan JonathanGENERAL COUNSEL & CORP SEC21,225Aug 18, 202610
Harrison Seth LoringDirector–Jul 17, 20262
McCauley ThomasChief Scientific Officer–Jul 17, 20261
Levin Arthur ADirector4,237Jun 5, 20264
Smith JulieDirector–Jun 5, 20261
Tzianabos ArthurDirector31,339Jun 5, 20262
Burstein JenniferDirector–Jun 5, 20261
Krainer Adrian R.Director283,302Jun 5, 20265
Kahn ClareDirector–Apr 7, 20261
Hoitt JasonChief Patient Officer10,276Mar 19, 20263
Leggett ThomasChief Financial Officer10,172Mar 19, 20263
Smith Ian FChief Executive Officer–Feb 19, 20262
Ezbon International Ltd10% Owner3,906,181IndirectJun 6, 20250
Blue Horizon Enterprise Ltd10% Owner3,906,181IndirectJun 6, 20250
Montrago Trustees Ltd10% Owner3,906,181IndirectJun 6, 20250
Skorpios Trust10% Owner3,906,181IndirectJun 6, 20250
Menzel Garry EDirector–Jun 4, 20250
Nash Huw M.Chief Business Officer0Jul 3, 20240
Tulipano Stephen JFormer CFO20,746Jun 7, 20240

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 2, 2021 (view filing)Jul 11 dayNash Huw M.COO & CBOSSale−5.70K$33.33−$190.0K−100.0%0 after
Jul 15, 2021 (view filing)Jul 132 daysTicho BarryChief Medical OfficerSSale−43.2K$32.75−$1.41M−24.8%130.9K after2 lots
Aug 4, 2021 (view filing)Aug 22 daysNash Huw M.COO & CBOSSale−5.70K$28.87−$164.6K−100.0%0 after
Sep 2, 2021 (view filing)Sep 11 dayNash Huw M.COO & CBOSSale−5.70K$26.00−$148.2K−100.0%0 after
Oct 4, 2021 (view filing)Oct 13 daysNash Huw M.COO & CBOSSale−5.70K$24.83−$141.5K−100.0%0 after
Nov 3, 2021 (view filing)Nov 1-32 daysNash Huw M.COO & CBOSSale−5.70K$24.03−$137.0K−100.0%0 after3 lots
Dec 3, 2021 (view filing)Dec 12 daysNash Huw M.COO & CBOSSale−5.70K$24.44−$139.3K−100.0%0 after2 lots
Jan 5, 2022 (view filing)Jan 32 daysNash Huw M.COO & CBOSSale−3.80K$23.07−$87.7K−100.0%0 after3 lots
Feb 2, 2023 (view filing)Jan 31-Feb 22 daysTicho BarryChief Medical OfficerSSale−6.17K$10.02−$61.8K−4.7%124.7K after3 lots
Feb 7, 2023 (view filing)Feb 3-64 daysTicho BarryChief Medical OfficerSSale−13.0K$10.02−$130.3K−10.4%111.7K after2 lots
May 3, 2023 (view filing)May 1-32 daysTicho BarryChief Medical OfficerSSale−55.2K$10.06−$555.2K−49.4%56.5K after3 lots
May 8, 2023 (view filing)May 44 daysTicho BarryChief Medical OfficerSSale−653$10.00−$6.53K−1.2%55.9K after
Jun 5, 2023 (view filing)Jun 14 daysTicho BarryChief Medical OfficerSSale−15.0K$11.13−$166.9K−26.8%40.9K after
Jun 23, 2023 (view filing)Jun 212 daysAllan JonathanGeneral Counsel & Corp SecSSale−1.95K$13.48−$26.3K−100.0%0 after10b5-1
Jul 6, 2023 (view filing)Jul 33 daysTicho BarryChief Medical OfficerSSale−15.0K$10.60−$159.0K−36.7%25.9K after
Jan 4, 2024 (view filing)Jan 22 daysTicho BarryChief Medical OfficerSSale−10.0K$5.74−$57.4K−37.1%17.0K after10b5-1
Feb 5, 2024 (view filing)Feb 14 daysTicho BarryCHIEF MEDICAL OFFICERSSale−10.0K$4.80−$48.0K−58.9%6.98K after10b5-1
Mar 5, 2024 (view filing)Mar 14 daysTicho BarryCHIEF MEDICAL OFFICERSSale−10.0K$7.75−$77.5K−80.1%2.48K after10b5-1
Mar 19, 2024 (view filing)Mar 19Same dayAllan JonathanGENERAL COUNSEL & CORP SECSSale−2.35K$6.10−$14.3K−23.3%7.72K after
Mar 19, 2024 (view filing)Mar 19Same dayKaye Edward M. MDCEOSSale−11.2K$6.10−$68.0K−13.9%69.3K after
Mar 19, 2024 (view filing)Mar 19Same dayNash Huw M.COO & CBOSSale−4.12K$6.10−$25.1K−26.6%11.3K after
Mar 19, 2024 (view filing)Mar 19Same dayTicho BarryCHIEF MEDICAL OFFICERSSale−4.12K$6.10−$25.1K−26.4%11.5K after
Mar 19, 2024 (view filing)Mar 19Same dayTulipano Stephen JCFOSSale−4.12K$6.10−$25.1K−16.6%20.7K after
Apr 1, 2024 (view filing)Mar 284 daysAllan JonathanGENERAL COUNSEL & CORP SECSSale−5.13K$13.20−$67.7K−66.4%2.60K after2 lots10b5-1
Apr 3, 2024 (view filing)Apr 12 daysTicho BarryCHIEF MEDICAL OFFICERSSale−9.43K$13.23−$124.7K−79.1%2.48K after10b5-1
Apr 3, 2024 (view filing)4:19 PM ETApr 12 daysNash Huw M.COO & CBOSSale−61.3K$13.23−$811.2K−100.0%0 after2 lots10b5-1
Apr 18, 2024 (view filing)4:16 PM ETApr 171 dayEzbon International Ltd and 3 others10% OwnerSSale−3.60M$11.60−$41.8M−24.9%10.8M after
May 3, 2024 (view filing)May 12 daysTicho BarryCHIEF MEDICAL OFFICERSSale−10.0K$11.37−$113.7K−80.1%2.48K after10b5-1
May 22, 2024 (view filing)May 202 daysAllan JonathanGENERAL COUNSEL & CORP SECSSale−8.60K$15.04−$129.3K−76.8%2.60K after10b5-1
May 22, 2024 (view filing)May 202 daysKaye Edward M. MDCEOSSale−42.4K$15.43−$653.5K−61.1%27.0K after2 lots10b5-1
May 22, 2024 (view filing)4:20 PM ETMay 202 daysNash Huw M.COO & CBOSSale−50.0K$15.39−$769.5K−100.0%0 after10b5-1
Jun 5, 2024 (view filing)Jun 32 daysTicho BarryCHIEF MEDICAL OFFICERSSale−10.0K$15.22−$152.2K−80.1%2.48K after2 lots10b5-1
Jul 3, 2024 (view filing)Jul 12 daysTicho BarryCHIEF MEDICAL OFFICERSSale−10.0K$13.75−$137.5K−80.1%2.48K after10b5-1
Jul 3, 2024 (view filing)Jul 21 dayNash Huw M.Chief Business OfficerSSale−2.50K$13.11−$32.8K−100.0%0 after2 lots10b5-1
Aug 5, 2024 (view filing)Aug 14 daysTicho BarryCHIEF MEDICAL OFFICERSSale−10.0K$14.58−$145.8K−80.1%2.48K after10b5-1
Sep 5, 2024 (view filing)Sep 32 daysTicho BarryCHIEF MEDICAL OFFICERSSale−10.0K$14.95−$149.5K−80.1%2.48K after2 lots10b5-1
Sep 23, 2024 (view filing)4:23 PM ETSep 194 daysEzbon International Ltd and 3 others10% OwnerSSale−1.94M$14.05−$27.2M−17.9%8.91M after
Oct 2, 2024 (view filing)Oct 11 dayTicho BarryCHIEF MEDICAL OFFICERSSale−10.0K$12.06−$120.6K−80.1%2.48K after10b5-1
Nov 5, 2024 (view filing)Nov 14 daysTicho BarryCHIEF MEDICAL OFFICERSSale−10.0K$12.68−$126.8K−80.1%2.48K after10b5-1
Dec 3, 2024 (view filing)Dec 21 dayTicho BarryCHIEF MEDICAL OFFICERSSale−10.0K$12.07−$120.7K−16.3%51.3K after10b5-1
Dec 10, 2024 (view filing)Dec 64 daysKaye Edward M. MDCEOSSale−6.17K$12.78−$78.9K−8.2%68.7K after
Dec 10, 2024 (view filing)Dec 64 daysAllan JonathanGENERAL COUNSEL & CORP SECSSale−9.70K$12.78−$123.9K−21.6%35.1K after
Dec 10, 2024 (view filing)Dec 64 daysTicho BarryCHIEF MEDICAL OFFICERSSale−13.9K$12.78−$178.2K−22.8%47.3K after
Dec 11, 2024 (view filing)Dec 92 daysKaye Edward M. MDCEOSSale−6.79K$12.99−$88.2K−9.9%61.9K after
Dec 11, 2024 (view filing)Dec 92 daysAllan JonathanGENERAL COUNSEL & CORP SECSSale−13.7K$13.61−$186.0K−38.9%21.5K after2 lots10b5-1
Dec 11, 2024 (view filing)Dec 92 daysTicho BarryCHIEF MEDICAL OFFICERSSale−2.59K$12.99−$33.6K−5.5%44.7K after
Dec 27, 2024 (view filing)5:13 PM ETDec 234 daysEzbon International Ltd and 3 others10% OwnerSSale−2.00M$11.50−$23.0M−22.5%6.91M after
Mar 20, 2025 (view filing)Mar 18-192 daysAllan JonathanGENERAL COUNSEL & CORP SECSSale−4.21K$8.49−$35.7K−11.8%31.6K after2 lots
Mar 20, 2025 (view filing)Mar 18-192 daysTicho BarryCHIEF MEDICAL OFFICERSSale−7.22K$8.49−$61.2K−10.6%60.6K after2 lots
Mar 20, 2025 (view filing)Mar 18-192 daysKaye Edward M. MDDirectorSSale−19.3K$8.49−$163.7K−12.2%139.3K after2 lots